NDC Package 79929-020-07 Desogestrel And Ethinyl Estradiol And Ethinyl Estradiol

Kit - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
79929-020-07
Package Description:
3 BLISTER PACK in 1 POUCH / 1 KIT in 1 BLISTER PACK
Product Code:
Proprietary Name:
Desogestrel And Ethinyl Estradiol And Ethinyl Estradiol
Non-Proprietary Name:
Desogestrel And Ethinyl Estradiol And Ethinyl Estradiol
Usage Information:
Desogestrel and Ethinyl Estradiol Tablets, USP and Ethinyl Estradiol Tablets, USP is indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception.Oral contraceptives are highly effective. Table II lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. The efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. Correct and consistent use of these methods can result in lower failure rates. TABLE II: Percentage of women experiencing an unintended pregnancy during the first year of typical use and the first year of perfect use of contraception and the percentage continuing use at the end of the first year, United States. % of Women Experiencing an Unintended Pregnancy within the First Year of Use% of Women Continuing Use at One YearaMethod(1)Typical Useb(2) Perfect Usec(3) (4)Chance d8585Spermicides e26640Periodic Abstinence2563Calendar9Ovulation Method3Sympto-Thermal f2Post-Ovulation1Withdrawal194Cap gParous Women402642Nulliparous Women20956SpongeParous Women402042Nulliparous Women20956Diaphragm g20656Condom hFemale (Reality)21556Male14361Pill571Progestin Only0.5Combined0.1IUDProgesterone T21.581Copper T 380A0.80.678LNg 200.10.181Depo-Provera0.30.370Norplant and Norplant-20.050.0588Female Sterilization0.50.5100Male Sterilization0.150.10100Adapted from Hatcher et al., 1998, ref #1.a) Among couples attempting to avoid pregnancy, the percentage who continue to use a method for one year. b) Among typical couples who initiate use of a method (not necessarily for the first time), the percentage who experience an accidental pregnancy during the first year if they do not stop use for any other reason. c) Among couples who initiate use of a method (not necessarily for the first time) and who use it perfectly (both consistently and correctly), the percentage who experience an accidental pregnancy during the first year if they do not stop use for any other reason. d) The percents becoming pregnant in columns (2) and (3) are based on data from populations where contraception is not used and from women who cease using contraception in order to become pregnant. Among such populations, about 89% become pregnant within one year. This estimate was lowered slightly (to 85%) to represent the percent who would become pregnant within one year among women now relying on reversible methods of contraception if they abandoned contraception altogether. e) Foams, creams, gels, vaginal suppositories, and vaginal film.f) Cervical mucus (ovulation) method supplemented by calendar in the pre-ovulatory and basal body temperature in the post-ovulatory phases. g) With spermicidal cream or jelly.h) Without spermicides.
11-Digit NDC Billing Format:
79929002007
NDC to RxNorm Crosswalk:
  • RxCUI: 248310 - ethinyl estradiol 0.01 MG Oral Tablet
  • RxCUI: 248310 - ethinyl estradiol 10 MCG Oral Tablet
  • RxCUI: 249357 - desogestrel 0.15 MG / ethinyl estradiol 0.02 MG Oral Tablet
  • RxCUI: 748797 - inert 1 MG Oral Tablet
  • RxCUI: 748797 - inert ingredients 1 MG Oral Tablet
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Naari Pte. Limited
    Dosage Form:
    Kit - A packaged collection of related material.
    Sample Package:
    No
    FDA Application Number:
    ANDA209170
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    04-05-2023
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 79929-020-07?

    The NDC Packaged Code 79929-020-07 is assigned to a package of 3 blister pack in 1 pouch / 1 kit in 1 blister pack of Desogestrel And Ethinyl Estradiol And Ethinyl Estradiol, a human prescription drug labeled by Naari Pte. Limited. The product's dosage form is kit and is administered via form.

    Is NDC 79929-020 included in the NDC Directory?

    Yes, Desogestrel And Ethinyl Estradiol And Ethinyl Estradiol with product code 79929-020 is active and included in the NDC Directory. The product was first marketed by Naari Pte. Limited on April 05, 2023 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 79929-020-07?

    The 11-digit format is 79929002007. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-279929-020-075-4-279929-0020-07